Search Results for: NITI aayog

Pfizer Covid-19 jabs protective against Beta, Gamma variant, Covaxin against Delta [Reports]

While Pfizer Covid-19 jabs protective against Beta, Gamma variant, while Covishiled was found to be behind blood clots which are rare in India, according to experts but Covaxin was found effective against Delta variant

Jun 11, 2021

Farmers of J&K deprived of benefits from progressive central laws [Details]

New laws have been automatically extended in J&K with the abrogation of Article 370 but the benefits of these laws are yet to reach the aggrieved farmers whose land was acquired for the ring road project

Jun 10, 2021

J&K did it: First village in India to vaccinate 100% of 18+ population [details]

In a landmark feat, J&K's Weyan village has managed to vaccinate 100 percent of the 18+ population after teams were deployed to take the jabs to the people in the hilly region.

Jun 7, 2021

Indian cos missing the bus on vaccines, mRNA-based technologies: Jefferies

Vaccines and mRNA-based technologies have rapidly emerged as promising new therapeutic modalities, but Indian companies are lagging behind in adopting these innovation platforms.

Jun 5, 2021

NITI Aayog submits privatisation list, Bank of Maha, Central Bank top candidates

NITI Aayog has submitted the names of two public sector banks (PSBs) and one public sector general insurer, which can be sold off under the government's new privatisation policy, to the Core Group of Secretaries on Disinvestment.

Jun 4, 2021

J&K scores better than top states in NITI Aayog index of states on SDGs [Details]

NITI Aayog's index of states on SDGs is out; J&K improves its ranking in almost all sectors. The UT's performance is excellent in health, education, generating renewal energy, improving sex ratio among others.

Jun 3, 2021

Adequate Covid vaccines from August onward: NITI Aayog CEO

There may be a slight demand-supply imbalance in vaccines during June-July but from August onwards, there will be an adequate number of doses available, NITI Aayog CEO Amitabh Kant has said.

Jun 3, 2021

Sputnik V manufacturing to start soon in India: V.K. Paul

The manufacturing of Russia's Sputnik V Covid-19 vaccine will start soon in India as the country has accomplished technology-transfer to Indian companies, said Dr Vinod K. Paul, chair of the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC) on Thursday.

May 27, 2021

Covaxin still not on WHO list; Govt denies reports it affects foreign travel plans [details]

Covaxin was approved for emergency use on January 3 in the absence of Phase 3 trial data

May 22, 2021

COVID second wave killing doctors despite getting the jab; raises concerns in India [details]

More than 96 lakh healthcare workers have received at least the first dose of the vaccine, with 66 lakh receiving both doses, as per data from the Ministry of Health.

May 19, 2021

Covaxin trials for 2-18 year group to begin in 10 days: Govt

Clinical trials to test Covaxin vaccine's efficacy in children between two to 18 years of age will begin in 10-12 days, top officials said on Tuesday.

May 19, 2021

Covaxin trials in children aged 2-18 years to commence soon; what should you know [details]

Following DGCI's nod, Bharat Biotech is commencing Covaxin trials in children aged between 2 and 18 years in the coming days.

May 18, 2021

Pfizer, Moderna Vaccines Show Limited Effectiveness Against B1617 Variant Of COVID [Details]

The WHO said in a note that preliminary laboratory studies have found that the mRNA vaccines from Pfizer and Moderna showed reduced effectiveness against the double mutant variant of COVID found in India.

May 13, 2021

Third wave of COVID inevitable, warns govt's Scientific Advisor

The Scientific Advisor said regular monitoring of the Covid-19 vaccines is needed for upgradation to deal with the new strains.

May 5, 2021

"Great leader, gentle soul"; NITI Aayog CEO's heartfelt tribute to former J&K Guv

NITI Aayog CEO Amitabh Kant shared a detailed post, mourning the loss of former J&K governor Jagmohan, while also highlighting his accomplishments.